IDEXX Laboratories, Inc. (IDXX) vs Illumina, Inc. (ILMN)

IDEXX Laboratories, Inc. and Illumina, Inc. are both Diagnostics & Research companies. IDEXX Laboratories, Inc. and Illumina, Inc. are of similar size ($43.1B and $40.5B). IDEXX Laboratories, Inc. trades at the lower P/E: 39.1× against 48.4×. IDEXX Laboratories, Inc. grew revenue faster over the last twelve months: 12.8% against 4.88%. IDEXX Laboratories, Inc. has the higher net margin (25.0% vs 18.4%) and the higher return on invested capital (48.9% vs 17.5%). Across the 22 metrics below, IDEXX Laboratories, Inc. leads on 15 and Illumina, Inc. on 7.

Valuation

Metric IDXX ILMN Diagnostics & Research median
P/E 39.10 48.43 35.56
P/S 9.72 8.81 4.37
P/B 27.44 13.94 3.06
Price to free cash flow 35.76 43.19 35.76
EV/EBITDA 27.59 34.96 24.35
EV/Sales 9.77 8.99 5.51
Earnings yield 2.56% 2.06% (1.89%)
Free cash flow yield 2.80% 2.32% (0.15%)

Profitability

Metric IDXX ILMN Diagnostics & Research median
Gross margin 62.45% 66.39% 50.89%
Operating margin 32.03% 19.65% (8.57%)
Net margin 25.03% 18.36% (6.37%)
Free cash flow margin 27.17% 20.72% 0.00%
Return on equity 74.21% 32.38% (2.92%)
Return on assets 33.65% 12.95% (6.71%)
Return on invested capital 48.87% 17.46% 0.00%

Growth

Metric IDXX ILMN Diagnostics & Research median
Revenue growth (TTM) 12.77% 4.88% 7.69%
EPS growth (last fiscal year) 22.59% 170.87% 25.92%
Revenue growth, 5-year CAGR 9.72% 6.04% 7.40%
Net income growth, 5-year CAGR 12.74% 5.32% 0.00%

Health

Metric IDXX ILMN Diagnostics & Research median
Debt to equity 0.28 0.53 0.11
Current ratio 1.17 1.80 2.02
Net debt to EBITDA 0.18 (0.13) 0.70

Dividend

Metric IDXX ILMN Diagnostics & Research median
Dividend yield — — 0.66%
Payout ratio — — 0.20

Size

Metric IDXX ILMN Diagnostics & Research median
Market cap 43.11b 40.46b 2.16b

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack